The EIT Health Start-ups Meet Pharma is a challenge-based acceleration program focused on selecting the most promising health start-ups and scale-ups matching the corporate partners’ innovation needs, to deliver solutions that address quality and affordable healthcare for European patients.
In 2022, we are enabling unparalleled exposure to industry executives and decision-makers at Novartis,Boehringer Ingelheim, Sintetica and Takeda through one-to-one pitch sessions, support, value proposition development and partnership exploration.
If you are developing innovative technologies and services representing potential solutions for the selected challenges for 2022,applynow!
Challenges for 2022:
Digital solutions improving referral and diagnostic pathway for rare diseasesin collaboration withTakeda
Early diagnosis and identification of risk for disease progression in Chronic Kidney patientsin collaboration withBoehringer Ingelheim RCV
Innovative solutions for pain managementin collaboration withSintetica
Care coordination between primary care and specialty care for Atherosclerotic Cardiovascular Disease patients with elevated LDL-c levelsin collaboration withNovartis
More information about the programme and its requirements is available at thislink.
The deadline for applications is14 March 2022and we are also organizing two webinarsaimed to provide a detailed overview of the programme, its timeline, and the application processon9 February 2022 at 11 AM CETand9 March 2022at11 AM CET.Interested parties can registerhere.